ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 683556 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 683556; 2) Community: the network communities that were significantly associated with the response to NSC 683556; 3) Molecule: the relationships between components within communities and NSC 683556; 4) MDR: the compounds that were significantly associated with the NSC 683556.

NSC Compound Enrichment Correlation
NSC 135687 5.beta.-Bufa-20,22-dienolide, 14,15.beta.-epoxy-3.beta.,5-dihydroxy-, 3-acetate (8CI) 0.00567322425730621 0.40900795
NSC 267713 Digitoxigenin glycoside 0.00567322425730621 0.38410096
NSC 328410 Camptothecin Derivative 0.00567322425730621 0.63226335
NSC 633271 Null 0.00567322425730621 0.017504919
NSC 673652 2-Ethylaminoestradiol 0.00567322425730621 0.1094534
NSC 681641 Camptothecin Derivative 0.00567322425730621 0.81723523
NSC 697286 LY 294002 0.00567322425730621 0.095800054
NSC 747180 Null 0.00627320055153809 -0.17804403
NSC 693543 4-Acridinecarboxamide, 9-amino-N-[3-[(2-aminoethyl)amino]propyl]-5-methyl-, trihydrochloride 0.00741876119839022 0.34526271
NSC 747252 Trihexyl(tetradecyl)Phosphonium Hexafluorophosphate 0.00741876119839022 -0.016815147
Total:51  Current:8    [First] [Prev] [Next] [Last]